Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem … – MENAFN.COM
Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem …MENAFN.COMSUNRISE, FL, Sep 23, 2013 (Menafn – Marketwired via COMTEX) –Bioheart, Inc. (otcqb:BHRT), a biotech company focused on thediscovery, development and commercialization of autologous celltherapies for the treatment of chronic and acute heart damage … and more …read more &nbs… Continue reading
